樂普醫療(300003.SZ)下屬子公司入選北京市開展新型冠狀病毒核酸檢測單位
格隆匯2月6日丨樂普醫療(300003.SZ)公佈,公司於今日接到下屬子公司北京愛普益醫學檢驗中心有限公司(愛普益醫學檢驗中心)的通知,根據北京市衞生健康委員會、北京市醫療保障局、北京市財政局聯合發佈的《關於醫療機構和第三方檢測機構開展新型冠狀病毒核酸檢測有關工作的通知》(京衞醫【2020】10號),愛普益醫學檢驗中心入選北京市第三批開展新型冠狀病毒核酸檢測單位。通知指出:“市、區疾控中心,經確認符合條件的醫院和第三方檢測機構出具的病原學檢測結果,均可作為確診依據。各醫療機構可結合工作實際,選擇符合條件的第三方檢測機構進行新型冠狀病毒感染的肺炎病例的病毒核酸檢測。”
愛普益醫學檢驗中心作為第三方醫學檢測機構,專業領域涵蓋生化、免疫、分子診斷、微生物、病理、遺傳代謝、血液病特檢等服務,業務區域輻射全國,專業化的實驗室為各級醫療衞生機構提供精準、高效、全面的醫學診斷外包服務。目前愛普益醫學檢驗中心開展新型冠狀病毒核酸檢測使用的設備為公司
IVD事業部子公司煙台艾德康生物科技有限公司生產的全自動核酸提取儀和北京樂普醫療科技有限責任公司生產的全自動醫用PCR分析系統,上述設備配合核酸檢測試劑來完成病毒核酸檢測。公司希望能夠幫助疾控中心、有條件的檢驗科及第三方檢驗機構,共同搭建新型冠狀病毒核酸檢測平台,提高核酸檢測能力,早日戰勝病毒。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.